SLSanghyun Lee

Sanghyun Lee

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sanghyun Lee has a total of 183 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    BRO is a proteinaceous binding receptor for human coronavirus OC43

    by Jaewon Song, Young-Jun Park, M Alexandra Tortorici, Li Zhang, Seokoh Moon, Amin Addetia, Vasisht V Poosapati, Christine A Tsu, Jack T Brown, Cameron Stewart, et al.

    Embecoviruses such as human coronavirus (HCoV) OC43 have long been viewed as sialic acid-dependent viruses that attach to cells through interactions with cell surface sialoglycans. Here, we identify a specific proteinaceous receptor that harbors the sialoglycan determinant and also contributes protein contacts for viral spike (S) recognition. Using an unbiased surfaceome CRISPR activation screen for OC43 spike binding, we discovered that the previously uncharacterized human gene C1ORF54 encodes this receptor, which we name Binding Receptor for OC43 (BRO). BRO engages the OC43 S N-terminal domain through O-linked 9-O-acetylated sialoside determinants and neighboring protein contacts. BRO expression in human cells promotes OC43 infection, whereas BRO knockout or blockade with the BRO ectodomain or anti-BRO antibody inhibit infection, including in differentiated primary human airway cultures. BRO orthologs from diverse mammals support OC43 infection when expressed in human cells, suggesting potential contributions to OC43 zoonotic circulation and cross-species transmission. Our findings reshape our understanding of OC43 entry, and pave the way to develop countermeasures targeting this receptor interaction.

  • IgA is necessary and sufficient to prevent norovirus infection in mice

    by Arya B. Ökten, Renata B. Filler, Justin L. Kung, Zhenhao Fang, Brieyanna C. McWilliams, Jenna E. Muscat-Rivera, Michael S. Kegel, Ilze M. Olivi Gomes, Madeleine C. Mankowski, Ashwin N. Skelly, et al.

    Human norovirus is the leading cause of viral gastroenteritis, yet effective vaccines and therapeutics remain elusive. Using murine norovirus as a model, we found that mucosal immunoglobulin A (IgA) is both necessary and sufficient for protection against infection, whereas CD8 + T cells are dispensable. Robust intestinal IgA production requires at least 4 weeks of enteric infection, consistent with kinetics of human norovirus RNA clearance. Systemic vaccination elicits high titers of neutralizing serum IgG but fails to prevent enteric norovirus infection, phenocopying a recent human norovirus vaccine failure. In contrast, prophylactic delivery of dimeric anti-norovirus IgA via mRNA lipid nanoparticles confers sterilizing immunity. Together, these findings define a critical role for mucosal IgA in norovirus protection and identify IgA-based treatments as a therapeutic approach for human norovirus.

  • Open Access

    TRIM47 inhibits murine norovirus replication in a strain-dependent manner

    by Stacey L. Crockett, Linley R. Pierce, Rachel Rodgers, Meagan Sullender, Lawrence A. Schriefer, Mridula Annaswamy Srinivas, Sanghyun Lee, Megan T. Baldridge, Robert C. Orchard

    Human norovirus is the leading cause of gastroenteritis worldwide. Norovirus exhibits remarkable genetic diversity. Understanding the impact of genetic diversity on infection and immunity has been challenging due to the difficulties in in vitro cultivation and the current lack of a small animal model. Murine norovirus (MNV) has emerged as a premier model system to investigate norovirus biology. Here, we identify TRIM47 as a host restriction factor that potently inhibits MNV infection in a strain-dependent manner. We determine that TRIM47 expression inhibits an early stage of the viral life cycle of the MNV strain CR6 (MNV CR6 ), while the replication of the closely related strain CW3 (MNV CW3 ) is not restricted by TRIM47. MNV CW3 causes an acute infection that spreads beyond intestinal tissues and is lethal to immunodeficient mice. In contrast, MNV CR6 fails to spread to systemic tissues but establishes a persistent infection by infecting intestinal tuft cells. Using a forward genetic screen, we determine that genetic variation within the nonstructural protein 1 (NS1) accounts for this differential sensitivity of MNV strains to TRIM47. While most TRIM-containing proteins promote the ubiquitination and degradation of their targets, TRIM47 does neither. Instead, TRIM47 promotes the deubiquitination of the NS1/2 precursor protein. Our data provide new insight into a potential antiviral gene and mechanistic insight into norovirus evolution that may impact viral tropism. IMPORTANCE: Viruses exist as genetically heterogeneous populations. Understanding the contribution of viral genetic variation to infection outcomes is critical in predicting emerging viruses and their variants. Noroviruses are genetically diverse, but human norovirus has been technically challenging to study. In this study, we use the model system murine norovirus to identify a viral strain-specific restriction mechanism where a host gene can specifically restrict one strain of the virus but has no impact on a closely related strain. Dissecting the mechanism of this specificity provides insight into viral diversity and possible host restriction pathways.

  • Open Access

    HKU5 bat merbecoviruses engage bat and mink ACE2 as entry receptors

    by Mia Madel Alfajaro, Emma L. Keeler, Ning Li, Nicholas J. Catanzaro, I-Ting Teng, Zhe Zhao, Michael W. Grunst, Boyd Yount, Alexandra Schäfer, Danyi Wang, et al.

    Identifying receptors for bat coronaviruses is critical for spillover risk assessment, countermeasure development, and pandemic preparedness. While Middle East respiratory syndrome coronavirus (MERS-CoV) uses DPP4 for entry, the receptors of many MERS-related betacoronaviruses remain unknown. The bat merbecovirus HKU5 was previously shown to have an entry restriction in human cells. Using both pseudotyped and full-length virus, we show that HKU5 uses Pipistrellus abramus bat ACE2 but not human ACE2 or DPP4 as a receptor. Cryo-electron microscopy analysis of the virus-receptor complex and structure-guided mutagenesis reveal a spike and ACE2 interaction that is distinct from other ACE2-using coronaviruses. MERS-CoV vaccine sera poorly neutralize HKU5 informing pan-merbecovirus vaccine design. Notably, HKU5 can also engage American mink and stoat ACE2, revealing mustelids as potential intermediate hosts. These findings highlight the versatility of merbecovirus receptor use and underscore the need for continued surveillance of bat and mustelid species.


  • Open Access

    Norovirus co-opts NINJ1 for selective protein secretion

    by Jaewon Song, Li Zhang, Seokoh Moon, Ariana Fang, Guoxun Wang, Newsha Gheshm, Skylar A. Loeb, Paul Cao, Joselynn R. Wallace, Mia Madel Alfajaro, et al.

    Plasma membrane rupture by Ninjurin-1 (NINJ1) executes programmed cell death, releasing large cellular damage-associated molecular patterns (DAMPs). However, the regulation and selectivity of NINJ1-mediated DAMP release remain unexplored. Here, we uncover that murine norovirus (MNoV) strategically co-opts NINJ1 to selectively release the intracellular viral protein NS1, while NINJ1-mediated plasma membrane rupture simultaneously bulk-releases various cellular DAMPs. Host caspase-3 cleaves the precursor NS1/2, leading to NS1 secretion via an unconventional pathway. An unbiased CRISPR screen identifies NINJ1 as an essential factor for NS1 secretion. During infection, NINJ1 is recruited to the viral replication site, where it oligomerizes and forms speckled bodies, directly interacting with NS1. Subsequent mutagenesis studies identify critical amino acid residues of NS1 necessary for its interaction with NINJ1 and selective secretion. Genetic ablation or pharmaceutical inhibition of caspase-3 inhibits oral MNoV infection in mice. This study underscores the co-option of NINJ1 for controlled release of an intracellular viral protein.


  • The neonatal Fc receptor is a cellular receptor for human astrovirus

    by Harshad Ingle, Jerome M. Molleston, Paige D. Hall, Duyen Bui, Leran Wang, Karan D. Bhatt, Lynne Foster, Avan Antia, Siyuan Ding, Sanghyun Lee, et al.

    Human astroviruses (HAstV) are major causes of gastroenteritis, especially in children, and there are no vaccines or antivirals currently available. Little is known about host factors required for their cellular entry. Here we utilized complementary CRISPR-Cas9-based knockout and activation screens to identify neonatal Fc receptor (FcRn) and dipeptidyl-peptidase IV (DPP4) as entry factors for HAstV infection in vitro. Disruption of FcRn or DPP4 reduced HAstV infection in permissive cells and, reciprocally, overexpression of these factors in non-permissive cells was sufficient to promote infection. We observed direct binding of FcRn, but not DPP4, with HAstV virions and the purified spike protein. This suggests that FcRn is a receptor for HAstVs while DPP4 is a cofactor for entry. Inhibitors for DPP4 and FcRn currently in clinical use prevented HAstV infection in cell lines and human enteroids. Our results reveal mechanisms of HAstV entry as well as druggable targets to limit HAstV infection.


  • Open Access

    CRISPR/Cas9 screens identify key host factors that enhance rotavirus reverse genetics efficacy and vaccine production

    by Yinxing Zhu, Meagan E. Sullender, Danielle E. Campbell, Leran Wang, Sanghyun Lee, Takahiro Kawagishi, Gaopeng Hou, Alen Dizdarevic, Philippe H. Jais, Megan T. Baldridge, et al.

    Rotaviruses pose a significant threat to young children. To identify novel pro- and anti-rotavirus host factors, we performed genome-wide CRISPR/Cas9 screens using rhesus rotavirus and African green monkey cells. Genetic deletion of either SERPINB1 or TMEM236, the top two antiviral factors, in MA104 cells increased virus titers in a rotavirus strain independent manner. Using this information, we optimized the existing rotavirus reverse genetics systems by combining SERPINB1 knockout MA104 cells with a C3P3-G3 helper plasmid. We improved the recovery efficiency and rescued several low-titer rotavirus reporter and mutant strains that prove difficult to rescue otherwise. Furthermore, we demonstrate that TMEM236 knockout in Vero cells supported higher yields of two live-attenuated rotavirus vaccine strains than the parental cell line and represents a more robust vaccine-producing cell substrate. Collectively, we developed a third-generation optimized rotavirus reverse genetics system and generated gene-edited Vero cells as a new substrate for improving rotavirus vaccine production.


  • Intestinal tuft cell immune privilege enables norovirus persistence

    by Madison S. Strine, Eric Fagerberg, Patrick W. Darcy, Gabriel M. Barrón, Renata B. Filler, Mia Madel Alfajaro, Nicole D’aNgelo-Gavrish, Fang Wang, Vincent R. Graziano, Bridget L. Menasché, et al.

    The persistent murine norovirus strain MNV CR6 is a model for human norovirus and enteric viral persistence. MNV CR6 causes chronic infection by directly infecting intestinal tuft cells, rare chemosensory epithelial cells. Although MNV CR6 induces functional MNV-specific CD8 + T cells, these lymphocytes fail to clear infection. To examine how tuft cells promote immune escape, we interrogated tuft cell interactions with CD8 + T cells by adoptively transferring JEDI (just EGFP death inducing) CD8 + T cells into Gfi1b-GFP tuft cell reporter mice. Unexpectedly, some intestinal tuft cells partially resisted JEDI CD8 + T cell–mediated killing—unlike Lgr5 + intestinal stem cells and extraintestinal tuft cells—despite seemingly normal antigen presentation. When targeting intestinal tuft cells, JEDI CD8 + T cells predominantly adopted a T resident memory phenotype with decreased effector and cytotoxic capacity, enabling tuft cell survival. JEDI CD8 + T cells neither cleared nor prevented MNV CR6 infection in the colon, the site of viral persistence, despite targeting a virus-independent antigen. Ultimately, we show that intestinal tuft cells are relatively resistant to CD8 + T cells independent of norovirus infection, representing an immune-privileged niche that can be leveraged by enteric microbes.


  • Open Access

    IFN-λ derived from nonsusceptible enterocytes acts on tuft cells to limit persistent norovirus

    by Harshad Ingle, Heyde Makimaa, Somya Aggarwal, Hongju Deng, Lynne Foster, Yuhao Li, Elizabeth A. Kennedy, Stefan T. Peterson, Craig B. Wilen, Sanghyun Lee, et al.

    Norovirus is a leading cause of epidemic viral gastroenteritis, with no currently approved vaccines or antivirals. Murine norovirus (MNoV) is a well-characterized model of norovirus pathogenesis in vivo, and persistent strains exhibit lifelong intestinal infection. Interferon-λ (IFN-λ) is a potent antiviral that rapidly cures MNoV. We previously demonstrated that IFN-λ signaling in intestinal epithelial cells (IECs) controls persistent MNoV, and here demonstrate that IFN-λ acts on tuft cells, the exclusive site of MNoV persistence, to limit infection. While interrogating the source of IFN-λ to regulate MNoV, we confirmed that MDA5-MAVS signaling, required for IFN-λ induction to MNoV in vitro, controls persistent MNoV in vivo. We demonstrate that MAVS in IECs and not immune cells controls MNoV. MAVS in nonsusceptible enterocytes, but not in tuft cells, restricts MNoV, implicating noninfected cells as the IFN-λ source. Our findings indicate that host sensing of MNoV is distinct from cellular tropism, suggesting intercellular communication between IECs for antiviral signaling induction in uninfected bystander cells.


  • Open Access

    Tuft-cell-intrinsic and -extrinsic mediators of norovirus tropism regulate viral immunity

    by Madison S. Strine, Mia Madel Alfajaro, Vincent R. Graziano, Jaewon Song, Leon L. Hsieh, Ryan Hill, Jun Guo, Kelli L. VanDussen, Robert C. Orchard, Megan T. Baldridge, et al.